Cargando…

Clinical breast cancer and estrogen

Detalles Bibliográficos
Autor principal:	Chew, HK
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300138/ http://dx.doi.org/10.1186/bcr677

Ejemplares similares

Pregnancy levels of estrogen prevents breast cancer
por: Nandi, S, et al.
Publicado: (2003)

Potential mechanisms whereby estrogens induce breast cancer in women
por: Santen, RJ, et al.
Publicado: (2005)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat
por: Shull, JD, et al.
Publicado: (2003)

Estrogen receptors α and β in the rodent mammary gland
por: Saji, S, et al.
Publicado: (2000)

Could estrogen impact a new pertinent gene for AIS?
por: Moldovan, Florina, et al.
Publicado: (2015)

Insulin resistance in breast cancer: relevance and clinical implications
por: Goodwin, PJ
Publicado: (2011)

Clinical utility and future of genetic profiles for breast cancer
por: Hudis, C
Publicado: (2009)

Estrogen receptors 1 and 2 genotypes and age at menarche in idiopathic scoliosis
por: Janusz, Piotr, et al.
Publicado: (2015)

Methods for gene expression profiling in clinical trials for breast cancer
por: Paik, S
Publicado: (2005)

Clinical trials in breast cancer; do we have the right approaches?
por: Lønning, PE
Publicado: (2000)

Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
por: Pusztai, L
Publicado: (2009)

Paravertebral deep back muscles of girls with idiopathic scoliosis reveal expression of receptors for estrogens
por: Kotwicki, Tomasz, et al.
Publicado: (2010)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Translating breast cancer research into clinical practice — new approaches and better outcomes
por: Johnston, SRD
Publicado: (2006)

The challenges in translating present knowledge of the molecular biology of breast cancer into clinical use
por: Davidson, N
Publicado: (2005)

The 'ideal' symptomatic breast clinic
por: Kissin, M
Publicado: (2006)

Symptomatic breast clinics: the radiologist's perspective
por: Michell, MJ
Publicado: (2006)

Epigenetics of breast cancer
por: Esteller, M
Publicado: (2011)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Long-term survival of interval breast cancers in breast cancer screening in Wales
por: Fong, YF, et al.
Publicado: (2012)

Replication study of estrogen receptor 1 XbaI polymorphism in adolescent idiopathic scoliosis (AIS) Caucasian population
por: Piotr, Janusz, et al.
Publicado: (2013)

Lessons from TP53 mutations in breast cancers: from carcinogen fingerprints to clinical correlates
por: Hainaut, P, et al.
Publicado: (2000)

Xenoreactive antibody response following pulmonary valve replacement using porcine bioprosthesis in the young
por: Kim, MS, et al.
Publicado: (2013)

Estrogen receptor alpha-positive and negative mouse mammary tumors through somatic mutations of p53 in mammary carcinogenesis
por: Lin, S-CJ, et al.
Publicado: (2003)

Sentinel node biopsy versus conventional axillary dissection in clinically node-negative breast cancer patients
por: Bear, HD
Publicado: (2005)

Update on breast cancer genetics
por: Izatt, L
Publicado: (2006)

Predictive factors in breast cancer
por: Klijn, J, et al.
Publicado: (2000)

Immunity and autoimmunity in breast cancer
por: Curigliano, G
Publicado: (2011)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Genomic profiling of breast cancer
por: Borg, Å
Publicado: (2005)

Is ultrasound axillary staging less accurate in invasive lobular breast cancer than in ductal breast cancer?
por: Sankaye, P, et al.
Publicado: (2012)

Scintimammographic findings with (99m)Tc-(V)DMSA and (99m)Tc-MIBI in usual-type ductal epithelial hyperplasia (HUT) and apocrine metaplasia (AM) of the breast, in relation with the cell proliferation index (Ki-67) and the presence of estrogen receptors (ERs)
por: Papantoniou, V, et al.
Publicado: (2004)

Promoting early presentation of breast cancer
por: Ramirez, AJ
Publicado: (2008)

Developing new treatments for breast cancer
por: Lane, D
Publicado: (2004)

Chemoprevention for breast cancer: current status
por: Boyle, P
Publicado: (2004)

Molecular heterogeneity of luminal breast cancer
por: Loi, S
Publicado: (2011)

Oral vinorelbine in metastatic breast cancer
por: Conte, PF, et al.
Publicado: (2005)

The role of Xeloda in metastasic breast cancer
por: Cortés-Funes, H
Publicado: (2005)

ATM mutations associated with breast cancer
por: Gatti, RA, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_hheaat8nm28iid3g5pndrea3l6